Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma

Clinical trial NCT00202930 · TERMINATED

Trial details

NCT number: NCT00202930
Sponsor: Jean M. Tersak, M.D.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroblastoma Opsoclonus-myoclonus

Start date: 2005-07-01
Primary completion: 2008-12-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.